Clinical Trial: Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Mesenchymal Stem Cells From Third-party Donors for Treatment of Refractory Acute Graft-versus-host Disease

Brief Summary: The purpose of this study is to evaluate the utility of treating patients experiencing refractory acute graft-versus-host disease with ex-vivo-expanded BM-drived mesenchymal stem cells from third-party donors. The objective was to evaluate the effect and safety of such treatment on refractory acute graft-versus-host disease.